Ad is loading...
JVMTX
Price
$31.30
Change
-$0.23 (-0.73%)
Updated
Nov 15 closing price
MCVAX
Price
$11.83
Change
-$0.08 (-0.67%)
Updated
Nov 15 closing price
Ad is loading...

JVMTX vs MCVAX

Header iconJVMTX vs MCVAX Comparison
Open Charts JVMTX vs MCVAXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$31.30
Change-$0.23 (-0.73%)
VolumeN/A
CapitalizationN/A
Transamerica Mid Cap Value Opps A
Price$11.83
Change-$0.08 (-0.67%)
VolumeN/A
CapitalizationN/A
JVMTX vs MCVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMTX vs. MCVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and MCVAX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.8B vs. MCVAX (1.23B). JVMTX pays higher dividends than MCVAX: JVMTX (0.73) vs MCVAX (0.52). JVMTX was incepted earlier than MCVAX: JVMTX (11 years) vs MCVAX (11 years). MCVAX is a more actively managed with annual turnover of: 44.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than MCVAX: JVMTX (0) vs MCVAX (1000). JVMTX annual gain was more profitable for investors over the last year : 21.44 vs. MCVAX (12.67). JVMTX return over 5 years is better than : 44.38 vs. MCVAX (1.29).
JVMTXMCVAXJVMTX / MCVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years11 years-
Gain YTD14.4849.032160%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B1.23B1,941%
Annual Yield % from dividends0.730.52139%
Returns for 1 year21.4412.67169%
Returns for 3 years7.23-21.35-34%
Returns for 5 years44.381.293,439%
Returns for 10 years60.9112.86474%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKD2.74-0.09
-3.18%
AMTD Digital
SPB88.22-5.64
-6.01%
Spectrum Brands Holdings
IPG27.09-2.11
-7.23%
Interpublic Group of Companies (The)
SBFM2.35-0.23
-8.75%
Sunshine Biopharma Inc
IKT2.05-0.31
-13.14%
Inhibikase Therapeutics